Article info

Download PDFPDF
Challenge to levetiracetam’s de facto position as generic first-line antiseizure medication

Authors

  1. Correspondence to Dr Aidan Neligan, Neurology, Homerton University Hospital, London, UK; a.neligan{at}ucl.ac.uk
View Full Text

Citation

Neligan A, Walker M, Rajakulendran S
Challenge to levetiracetam’s de facto position as generic first-line antiseizure medication

Publication history

  • Accepted September 23, 2021
  • First published October 5, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Other content recommended for you